Here are the 8-K filings from XFLH Capital Corporation (XFLH) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow XFLH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full XFLH filings page.
XFLH Capital Corporation (XFLH), a Cayman Islands special purpose acquisition company, reported that on September 18, 2026 it entered into a non-binding Letter of Intent with Renogen Biolab Inc., a Canadian health service provider focused on molecular capabilities including DNA services, vector engineering, and protein expression, for a proposed business combination. Under the Letter of Intent, both parties agreed to use reasonable best efforts and act in good faith to negotiate definitive agreements as soon as practicable and to provide each other reasonable access to information for due diligence. On September 22, 2026, XFLH announced the Letter of Intent in a press release furnished as an exhibit. The company states that any definitive agreement, if reached, would later be described in a proxy statement to be filed with the SEC for stockholder consideration, and clarifies that this announcement does not constitute an offer or solicitation for any securities.
XFLH Capital Corporation reported that investors who bought its 10,000,000 units in the initial public offering can start trading the components separately. Beginning March 9, 2026, each unit’s ordinary share and right may trade on the NYSE under the symbols XFLH and XFLHR, while intact units remain under XFLHU.
Each unit consists of one ordinary share and one right to receive one-seventh of a share upon completion of the company’s first business combination. Holders must ask their brokers to work with Continental Stock Transfer & Trust Company to split units into separate shares and rights.
XFLH Capital Corporation completed its initial public offering of 10,000,000 units at $10.00 each, raising gross proceeds of $100,000,000. Each unit includes one ordinary share and one right to receive one-seventh of an ordinary share after a business combination.
The company also sold 154,970 private units to its sponsor for $1,549,700, and a total of $100,000,000 was placed in a U.S. trust account for the benefit of public shareholders. As of February 13, 2026, XFLH reported total assets of $100,593,400, including $574,604 of cash outside the trust for working capital, and it has 15 months from the IPO closing to complete an initial business combination or redeem the public shares.
XFLH Capital Corporation, a Cayman Islands blank check company, completed its initial public offering of 10,000,000 units at $10.00 each, raising gross proceeds of $100,000,000. Each unit consists of one ordinary share and one right to receive one-seventh of an ordinary share upon a future business combination.
The units trade on the NYSE under the symbol XFLHU, with the ordinary shares and rights expected to trade separately as XFLH and XFLHR. Underwriters have a 45-day option to purchase up to 1,500,000 additional units to cover over-allotments.
Simultaneously, the sponsor purchased 154,970 private placement units for $1,549,700, including cancellation of $278,496 of debt. As of February 13, 2026, a total of $100,000,000 from the IPO and private placement was deposited into a U.S. trust account, to be released only upon a business combination or specified shareholder redemptions, with a 15‑month deadline from IPO closing.